Episomal persistence of recombinant adenoviral vector Genomes during the cell cycle in vivo

被引:72
作者
Ehrhardt, A
Xu, H
Kay, MA
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
关键词
D O I
10.1128/JVI.77.13.7689-7695.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Previously we showed that recombinant adenoviral helper-dependent (HD) vectors result in long-term transgene expression levels in vivo which slowly declined by 95% over a period of 1 year. In this study, we further establish that this was not predominantly immune mediated. To determine if cell turnover was responsible for the loss of transgene expression, we induced rapid hepatocyte cell cycling in mouse liver, by performing a surgical two-thirds partial hepatectomy. We observed a 55 and 65% reduction in transgene expression levels and a 50 and 71% loss of vector genomes for the HD vector and the first-generation adenoviral vector. In sharp contrast, in nonviral, episomal plasmid DNA-injected mice, transgene expression levels and DNA copy numbers decreased by 95 and 99%, respectively. These findings suggest that cell division alone was not the primary reason for the slow decrease in transgene expression levels and that recombinant adenoviral vectors have a more robust mechanism for maintaining persistence during cell cycling. Several potential mechanisms are proposed.
引用
收藏
页码:7689 / 7695
页数:7
相关论文
共 38 条
[1]   Adenovirus preterminal protein binds to the CAD enzyme at active sites of viral DNA replication on the nuclear matrix [J].
Angeletti, PC ;
Engler, JA .
JOURNAL OF VIROLOGY, 1998, 72 (04) :2896-2904
[2]   Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix [J].
Baiker, A ;
Maercker, C ;
Piechaczek, C ;
Schmidt, SBA ;
Bode, J ;
Benham, C ;
Lipps, HJ .
NATURE CELL BIOLOGY, 2000, 2 (03) :182-184
[3]  
BARR D, 1995, GENE THER, V2, P151
[4]   Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo [J].
Brough, DE ;
Hsu, C ;
Kulesa, VA ;
Lee, GM ;
Cantolupo, LJ ;
Lizonova, A ;
Kovesdi, I .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9206-9213
[5]   Stability without a centromere [J].
Calos, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4084-4085
[6]   Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver [J].
Chen, ZY ;
Yant, SR ;
He, CY ;
Meuse, L ;
Shen, S ;
Kay, MA .
MOLECULAR THERAPY, 2001, 3 (03) :403-410
[7]   Optimization of cis-acting elements for gene expression from nonviral vectors in vivo [J].
Ehrhardt, A ;
Peng, PD ;
Xu, H ;
Meuse, L ;
Kay, MA .
HUMAN GENE THERAPY, 2003, 14 (03) :215-225
[8]   A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo [J].
Ehrhardt, A ;
Kay, MA .
BLOOD, 2002, 99 (11) :3923-3930
[9]   ADENOVIRUS PRECURSOR TO TERMINAL PROTEIN INTERACTS WITH THE NUCLEAR MATRIX INVIVO AND INVITRO [J].
FREDMAN, JN ;
ENGLER, JA .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3384-3395
[10]  
Grave L, 2000, J GENE MED, V2, P433